NetworkNewsBreaks

FridayMay 23, 2025 12:34 pm

NetworkNewsBreaks – Beam Therapeutics Inc. (NASDAQ: BEAM) to Present New Sickle Cell Data from BEACON Trial at EHA2025 

Beam Therapeutics (NASDAQ: BEAM), a biotechnology firm pioneering precision genetic medicines via base editing, announced it will present updated data from its BEACON Phase 1/2 trial of BEAM-101 at the European Hematology Association 2025 Congress, June 12-15 in Milan. BEAM-101 is an investigational, one-time ex vivo cell therapy targeting severe vaso-occlusive crises in sickle cell disease (SCD). The new data, covering safety and efficacy outcomes in 17 patients, will be highlighted during multiple poster sessions on June 13, underscoring BEAM-101’s potential to provide a durable treatment by addressing the root cause of SCD. Additional presentations will explore biomarkers, manufacturing advances,…

Continue Reading

FridayMay 23, 2025 9:28 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands Global Reach with Juve Stabia Serie A Playoff Match Streaming in U.S., Canada and UK 

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B club S.S. Juve Stabia will stream its second Serie A playoff semifinal match against Cremonese live and free on Sunday, May 25, via Destination Calcio TV in the U.S., Canada and the UK. This follows Juve Stabia’s 2-1 win in the first leg. The international broadcast underscores Brera’s strategy to grow Juve Stabia’s global visibility through media access, fan engagement, and its multi-club ownership model. Executive Chairman Daniel McClory said the exposure builds the club’s audience in key markets and highlights its compelling underdog narrative following its upset of City…

Continue Reading

FridayMay 23, 2025 9:10 am

NetworkNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports $58.2 Million Net Income for Fiscal 2025, Revenue Up 39 Percent

Silvercorp Metals (TSX: SVM) (NYSE American: SVM)  reported $58.2 million in net income for the fiscal year ended March 31, 2025, up 60% from the prior year, on revenue of $298.9 million, a 39% increase. Fiscal 2025 production included 7.5K oz of gold, 6.9M oz of silver, 62.2M lb of lead and 23.3M lb of zinc. The company also posted adjusted earnings of $75.1 million or $0.37 per share, with cash flow from operations reaching $138.6 million. In Q4, Silvercorp reported a net loss of $7.6 million due to a $20.6 million non-cash derivative charge, but adjusted quarterly net income came…

Continue Reading

ThursdayMay 22, 2025 3:55 pm

NetworkNewsBreaks – Soligenix Inc.’s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare Cancer Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell lymphoma (“CTCL”), a rare form of cancer that affects the skin. “Soligenix’s proprietary treatment, HyBryte(TM), is currently in clinical trials, and the latest results have shown promising efficacy in treating CTCL,” reads a recent article. “‘Following 18 weeks of treatment, 75% of patients achieved ‘Treatment Success,’ reinforcing HyBryte(TM) as a potentially safe and fast-acting therapy for this chronic and underserved cancer,’ the company reported. The study results suggest that the treatment may be highly effective in reducing…

Continue Reading

ThursdayMay 22, 2025 2:55 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) RTNova Shows Promise in Targeted Tumor Therapy

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The innovative platform not only targets cancer cells effectively but also minimizes harm to surrounding healthy tissues, potentially improving treatment outcomes and reducing side effects. As global cancer rates continue to rise, Calidi’s RTNova platform and tumor-specific virotherapy hold the promise of offering new hope to cancer patients, addressing the limitations of existing treatments, and potentially improving survival rates across multiple cancer types. The company’s ongoing research and deep commitment to scientific excellence position…

Continue Reading

ThursdayMay 22, 2025 2:18 pm

NetworkNewsBreaks – Precision Meets Performance: Newton Golf Company Inc.’s (NASDAQ: NWTG) Fitted Shafts Elevate the Game

Newton Golf Company (NASDAQ: NWTG) is revolutionizing golf performance through its high-quality, custom-fitted shafts engineered to match individual swing dynamics. Recognizing the shaft as the “engine” of the club, Newton leverages advanced technology to optimize swing speed, ball trajectory and overall control. Crafted in the U.S. and engineered to meet the demands of players on professional tours, 30 PGA TOUR Champions players trust the shaft—including major winner Doug Barron. From seasoned pros to players across all skill levels, the company delivers precision equipment that minimizes inconsistencies and enhances shot accuracy for all golf enthusiasts. As personalized equipment gains traction in the…

Continue Reading

ThursdayMay 22, 2025 10:17 am

NetworkNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference

Intelligent Bio Solutions (NASDAQ: INBS) announced its participation at the RISE25 conference in Kissimmee, Florida, from May 28 to 31, 2025, where it will support U.S. distribution partner SMARTOX. INBS will demonstrate its Intelligent Fingerprinting Drug Screening System—a non-invasive, rapid test using fingerprint sweat to detect substances like THC, cocaine, methamphetamine, and opiates. With results delivered in under ten minutes, the technology is well-suited for treatment courts and justice applications. INBS views the event as a key platform to engage stakeholders as it advances toward U.S. market entry.  To view the full article, visit https://nnw.fm/OAcjY  About Intelligent Bio Solutions Inc. …

Continue Reading

ThursdayMay 22, 2025 9:30 am

NetworkNewsBreaks – Fusion Fuel Green PLC (NASDAQ: HTOO) Subsidiary Al Shola Gas Secures $2.7M in Engineering Contracts, Expands UAE Utility Portfolio 

Fusion Fuel Green (NASDAQ: HTOO) announced its majority-owned subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), secured approximately $2.7 million in new engineering contracts since March 2025. Additionally, the subsidiary added more than 1,800 residential service contracts and two commercial contracts since January, boosting expected recurring revenue by over $900,000. Al Shola Gas now serves over 12,000 customers and supplies more than 600 MT of LPG monthly, with plans to reach 800 MT by year-end.  To view the full press release, visit https://nnw.fm/cJaFC  About Fusion Fuel Green PLC  Fusion Fuel Green PLC (NASDAQ: HTOO) is an emerging…

Continue Reading

WednesdayMay 21, 2025 2:15 pm

NetworkNewsBreaks – Amazon.com Inc. (NASDAQ: AMZN) Appears Undervalued Amid Strong Growth in AWS and Advertising

Amazon.com (NASDAQ: AMZN) is drawing investor attention as a potential bargain, despite a 6.3% decline in its stock price year to date. Analysts highlight the company's robust performance in high-margin sectors such as Amazon Web Services (AWS) and advertising, which are contributing significantly to its profitability. AWS now generates over $100 billion in annual revenue, while the advertising segment boasts $70 billion, both exhibiting strong growth trajectories. Additionally, Amazon's North American retail margins are expanding, and the company is investing heavily in automation and infrastructure, including the upcoming Project Kuiper satellite internet initiative. These factors suggest that Amazon's current stock…

Continue Reading

WednesdayMay 21, 2025 1:59 pm

NetworkNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Gains Momentum as Loop Capital Projects 27% Upside

NVIDIA (NASDAQ: NVDA) is experiencing renewed investor optimism following Loop Capital's recent upgrade of its price target from $120 to $175, suggesting a potential 27% upside. The firm maintains a "Buy" rating, citing NVIDIA's dominant position in the AI infrastructure market and its strong growth prospects in data center spending. Analysts highlight NVIDIA's comprehensive technology stack and its extensive developer ecosystem as key factors reinforcing its leadership in AI and accelerated computing.   As of 1:44 PM EST on May 21, 2025, NVIDIA's stock is trading at $134.24, reflecting a slight decrease of $0.14 (0.10%) from the previous close. The stock…

Continue Reading